HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lynn K Struck Selected Research

Parkinson Disease (Parkinson's Disease)

1/2010Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lynn K Struck Research Topics

Disease

1Edema (Dropsy)
01/2010
1Hallucinations (Hallucination)
01/2010
1Disorders of Excessive Somnolence (Hypersomnia)
01/2010
1Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
01/2010
1Parkinson Disease (Parkinson's Disease)
01/2010

Drug/Important Bio-Agent (IBA)

1amsonic acid (DAS)IBA
01/2010
1ropinirole (Requip)FDA LinkGeneric
01/2010
1Pramipexole (Mirapex)FDA LinkGeneric
01/2010
1Selegiline (E250)FDA LinkGeneric
01/2010
1Dopamine Agonists (Dopamine Agonist)IBA
01/2010